PegIntron (peginterferon alfa-2b)

BIOLOGICAL3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Hepatitis CHepatitis C, Chronic

Phase 2

Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

CompletedNCT00787371

Merck Sharp & Dohme LLCHepatitis C, Hepatitis C, Chronic

Start: 2005-06-30End: 2006-07-31Updated: 2017-03-13

Phase 3

The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833)

TerminatedNCT00441584

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2005-07-31End: 2008-06-30Updated: 2017-04-05

Unknown Phase

Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)

CompletedNCT00725205

Merck Sharp & Dohme LLCHepatitis C, Hepatitis C, Chronic

Start: 2006-03-31End: 2010-10-31Updated: 2015-10-08